World Stereotactic Surgery Devices Market: Alarming Rise in Chronic Neurological Anomalies to Boost Adoption globally

The global stereotactic surgery devices market is likely to be driven by the high prevalence of people suffering from Parkinson’s disease, states Transparency Market Research (TMR) in a market research report. The report is titled, “Stereotactic Surgery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015–2023.” The report presents an outline of the growth trajectory of the global stereotactic surgery devices market along with the prevailing trends. An assessment of the dynamics that are likely to impact the growth of the market in a positive or negative manner has also been offered in the report. The competitive landscape along with information about the market shares, products and strategies of key players has been analyzed in the report.

Read Full Report: http://www.transparencymarketresearch.com/stereotactic-surgery-devices-market.html

Stereotactic frames and image based planning software are designed and developed for radio frequency generator and stereotactic surgeries. Stereotactic surgery, commonly known as stereotaxy is a minimally invasive process that can be employed for both therapeutic and diagnostic purposes. It involves the employment of a 3D coordinate system to stereotactically confine any point in a three dimensional space. This technique is used to perform procedures such as radiosurgery, biopsy, implantation, lesion, ablation, and injection. During surgeries, the image based planning software is used to guide the surgeon towards the respective target.

To achieve an enhanced level of accuracy for the localization of intracranial targets during the treatment of arteriovenous malformations (AVMs), epilepsy, and Parkinson’s disease, the adoption of stereotactic procedures is increasing extensively. As a result of this, the demand for stereotactic surgery devices is also rising. The demand for these devices is also expected to intensify over a couple of years owing to a robust rise in the geriatric population and prevalence of AVMs, epilepsy, and Parkinson’s disease worldwide. As per the survey of the U.S. Parkinson’s Disease Foundation, each year over 60,000 people in the U.S. are diagnosed with this disease. On the account of the increasing incidences of such neurological diseases, the global market for stereotactic surgery devices is expected to experience prominent growth during the forecast period.

Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4066

Geographically, the market has been categorized into Asia Pacific, North America, Europe, and the Rest of the World. Amidst these, North America emerged dominant with the leading share in 2013 in the market, closely trailed by Europe and Asia Pacific. Leading manufacturers are continuously making concerted efforts to develop advanced stereotactic surgery devices. Some of these key players include Micromar, Alliance Oncology, adeor Medical AG, Monteris Medical, Inomed, and Elekta AB.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.